← FDA ENFORCEMENT
D-0023-2026Class III

STAQ Pharma, Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
STAQ Pharma, Inc.
Product type
Drug
Status
Ongoing
Report date
2025-10-22
Distribution
Nationwide in the U.S.
Firm state
CO
Initiated by
Voluntary: Firm initiated
Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Product description

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Code / lot info

Lot #: 25104595A, Expiry: 27DEC2025.

Other recalls SPEQ maps to Documentation & Change Control
See all Documentation & Change Control recalls →

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →